title: MR quantitative biomarkers of non-alcoholic fatty liver disease: technical evolutions and future trends.
abstract: Non-alcoholic fatty liver disease (NAFLD) is characterized by hepatic steatosis as the earliest manifestation and hallmark, and ranges from benign fatty liver to non-alcoholic steatohepatitis (NASH). Liver biopsy (LB) is considered the reference standard for NAFLD diagnosis, grading and characterization, but it is limited by its invasiveness and observer-dependence. Among imaging surrogates for the assessment of hepatic steatosis, MR is the most accurate. (1)H MR spectroscopy (MRS) provides a quantitative biomarker of liver fat content (LFC) called proton density fat fraction (PDFF), but it is time-consuming, not widely available and limited in sample size. Several MR imaging (MRI) techniques, in particular fat suppression and in-opposed phase techniques, have been used to quantify hepatic steatosis, mainly estimating LFC from water and fat signal intensities rather than proton densities. Several technical measures have been introduced to minimize the effect of confounding factors, in particular a low flip angle, a multiecho acquisition and a spectral modeling of fat with multipeak reconstruction to address respectively T1 effect, T2* effect, and the multifrequency interference effects of fat protons, allowing to use MRI to estimate LFC based on PDFF. Tang et al. evaluated MRI-estimated PDFF, obtained by applying the above-mentioned technical improvements, in the assessment of hepatic steatosis, using histopathology as the reference standard. The identification of PDFF thresholds, even though to be further explored and validated in larger and more diverse cohorts, is useful to identify steatosis categories based on MRI-based steatosis percentages. MRI, with the new refined techniques which provide a robust quantitative biomarker of hepatic steatosis (PDFF) evaluated on the whole liver parenchyma, is a promising non-invasive alternative to LB as the gold standard for steatosis diagnosis and quantification.
authors.affiliation: Department of Radiology, University of Modena and Reggio Emilia, Italy;
authors.forename: Guido
authors.initials: G
authors.lastname: Ligabue
authors.forename: Giulia
authors.initials: G
authors.lastname: Besutti
authors.forename: Riccardo
authors.initials: R
authors.lastname: Scaglioni
authors.forename: Chiara
authors.initials: C
authors.lastname: Stentarelli
authors.forename: Giovanni
authors.initials: G
authors.lastname: Guaraldi
keywords: Magnetic Resonance Imaging (MRI); Non-alcoholic fatty liver disease (NAFLD); PDFF thresholds; confounding factors; histopathology; proton density fat fraction (PDFF)
references.citation: Am J Physiol Endocrinol Metab. 2005 Feb;288(2):E462-8
references.pmid: 15339742
references.citation: World J Gastroenterol. 2008 Apr 28;14(16):2474-86
references.pmid: 18442193
references.citation: Magn Reson Med. 1991 Apr;18(2):371-83
references.pmid: 2046518
references.citation: Hepatology. 2005 Jun;41(6):1313-21
references.pmid: 15915461
references.citation: Magn Reson Med. 2007 Aug;58(2):354-64
references.pmid: 17654578
references.citation: Radiology. 1984 Oct;153(1):189-94
references.pmid: 6089263
references.citation: Magn Reson Imaging. 1997;15(3):287-93
references.pmid: 9201675
references.citation: Radiology. 2009 Jan;250(1):130-6
references.pmid: 19017926
references.citation: AJR Am J Roentgenol. 2012 Mar;198(3):582-8
references.pmid: 22357996
references.citation: Liver Int. 2008 May;28(5):650-8
references.pmid: 18331241
references.citation: Radiology. 2009 Apr;251(1):67-76
references.pmid: 19221054
references.citation: J Magn Reson Imaging. 2011 Oct;34(4):729-749
references.pmid: 22025886
references.citation: Magn Reson Med. 2008 Nov;60(5):1122-34
references.pmid: 18956464
references.citation: J Hepatol. 2009 Sep;51(3):433-45
references.pmid: 19604596
references.citation: Radiology. 2007 Feb;242(2):450-5
references.pmid: 17255416
references.citation: J Magn Reson Imaging. 2011 Oct;34(4):928-34
references.pmid: 21769986
references.citation: Radiology. 2008 May;247(2):550-7
references.pmid: 18349314
references.citation: Antivir Ther. 2012;17(6):965-71
references.pmid: 22766513
references.citation: Radiology. 2013 May;267(2):422-31
references.pmid: 23382291
references.citation: J Magn Reson Imaging. 2007 Mar;25(3):644-52
references.pmid: 17326087
references.citation: Radiology. 2008 Oct;249(1):160-6
references.pmid: 18796674
references.citation: Ann Surg. 2009 Nov;250(5):691-7
references.pmid: 19806055
references.citation: J Magn Reson Imaging. 2010 Jan;31(1):4-18
references.pmid: 20027567
references.citation: Radiology. 2011 Mar;258(3):767-75
references.pmid: 21248233